News
-
-
-
COMMUNIQUÉ DE PRESSE
As Crisis Events Intensify, BlackBerry and the American Red Cross Renew Commitment to Secure and Trusted Emergency Communications
BlackBerry Secure Communications renews partnership with American Red Cross to support disaster response and humanitarian operations through secure solutions -
-
-
COMMUNIQUÉ DE PRESSE
NanoViricides, Inc. Has Filed its Annual Report: Broad-spectrum Antiviral NV-387 Is In Phase II Clinical Trials
NanoViricides, Inc. reports filing the Annual Report on Form 10-K with SEC showcasing achievements including Phase II trials for NV-387, an antiviral drug for Mpox and Ebola. Financials and milestones are detailed -
-
-
-